Valuation: AtriCure, Inc.

Market Cap 304.59Cr 271.94Cr 249.54Cr 227Cr 425.59Cr 29TCr 434.07Cr 2.98TCr 1.2TCr 15TCr 1.14TCr 1.12TCr 48TCr P/E 2026 *
561x
P/E 2027 * 142x
Enterprise Value 289.4Cr 258.38Cr 237.1Cr 215.68Cr 404.37Cr 27TCr 412.42Cr 2.83TCr 1.14TCr 14TCr 1.09TCr 1.06TCr 46TCr EV / Sales 2026 *
4.77x
EV / Sales 2027 * 4.14x
Free-Float
96.24%
Yield 2026 *
-
Yield 2027 * -
1 day-2.24%
1 week-1.96%
Current month-2.24%
1 month+8.60%
3 months+58.58%
6 months+106.34%
Current year+51.37%
1 week 59.14
Extreme 59.135
63
1 month 51.63
Extreme 51.63
63
Current year 25.36
Extreme 25.36
63
1 year 25.36
Extreme 25.36
63
3 years 18.94
Extreme 18.94
63
5 years 18.94
Extreme 18.94
89.18
10 years 14.78
Extreme 14.78
89.18
Manager TitleAgeSince
Chief Executive Officer 55 02/11/2012
Director of Finance/CFO 48 01/07/2014
Chief Tech/Sci/R&D Officer 59 18/07/2017
Director TitleAgeSince
Director/Board Member 55 02/11/2012
Director/Board Member 64 11/03/2013
Director/Board Member 75 10/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
23/09/26 Sell

Chief Technology Officer

-4,519 0.0089%
11/09/26 Sell

Director

-5,313 0.0104%
08/09/26 Sell

Chief Technology Officer

-3,657 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%-1.96%+73.31%+63.70% 304.59Cr
+3.73%+5.03%-10.89%+14.80% 19TCr
+2.85%+4.75%+9.47%+37.73% 12TCr
+5.12%+0.22%-13.88%+10.27% 12TCr
+1.41%+6.80%-41.10%+6.45% 9.62TCr
+2.12%+2.38%+0.01%+75.79% 6.45TCr
-5.48%-5.11%-1.24%+61.88% 5.25TCr
+0.36%+1.13%+11.13%-22.40% 5.41TCr
+21.85%+17.79%+6.69%+60.13% 5.29TCr
+2.23%+4.24%+1.04%-8.32% 3.56TCr
Average +3.20%+3.28%+3.46%+30.00% 7.88TCr
Weighted average by Cap. +3.67%+3.92%-6.79%+24.41%

Financials

2026 *2027 *
Net sales 61Cr 54Cr 50Cr 45Cr 85Cr 5.74TCr 86Cr 593.26Cr 239.14Cr 3.03TCr 227.54Cr 222.69Cr 9.57TCr 68Cr 61Cr 56Cr 51Cr 95Cr 6.44TCr 97Cr 665.65Cr 268.32Cr 3.4TCr 255.3Cr 249.86Cr 11TCr
Net income 71.32L 63.68L 58.43L 53.15L 99.66L 68Cr 1.02Cr 6.98Cr 2.81Cr 36Cr 2.68Cr 2.62Cr 112.57Cr 2.09Cr 1.86Cr 1.71Cr 1.56Cr 2.92Cr 197.73Cr 2.98Cr 20Cr 8.24Cr 104.37Cr 7.84Cr 7.67Cr 329.64Cr
Net Debt -15Cr -14Cr -12Cr -11Cr -21Cr -1.44TCr -22Cr -148.62Cr -60Cr -758.92Cr -57Cr -56Cr -2.4TCr -23Cr -20Cr -19Cr -17Cr -32Cr -2.14TCr -32Cr -221.71Cr -89Cr -1.13TCr -85Cr -83Cr -3.58TCr
Projected Income Statement - Annual - AtriCure, Inc.
Logo AtriCure, Inc.
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
Employees
1,350
Date Price Change Volume
02/26/02 $59.88 -2.24% 11,22,932
30/26/30 $61.25 -1.97% 9,67,355
29/26/29 $62.48 +1.73% 7,02,373
28/26/28 $61.42 -0.15% 6,47,551
27/26/27 $61.51 +0.70% 7,83,200
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - AtriCure, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
59.88USD
Average target price
57.56USD
Spread / Average Target
-3.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - AtriCure, Inc.
  1. Stock Market
  2. Stocks
  3. ATRC Stock